Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded a Revision: v3.4.3 label and removed the Revision: v3.4.2 label from the page; the change affects only metadata and does not alter study content or data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated to v3.4.2; the operating-status notice and the prior revision note (v3.4.1) were removed.SummaryDifference0.4%

- Check46 days agoChange DetectedA site-wide notice about government funding lapse affecting data currency was added, and the page footer shows Revision: v3.4.1 replacing v3.4.0.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page adds a glossary display and updates several metadata labels (e.g., capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), along with a new revision label 'v3.4.0'. Older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision: v3.3.4 was released, replacing v3.3.3. This appears to be a backend/format update without changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.